ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$7.80
+0.74 (+10.48%)
Open$7.65
Previous Close$7.06
Day High$7.92
Day Low$7.59
52W High$1,050.00
52W Low—
Volume—
Avg Volume31.9K
Market Cap10.01M
P/E Ratio—
EPS$-168.87
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 159.7K | 2.20M | 2.09M |
| Net Income | -630,621,419 | 266.8K | 312.0K |
| Profit Margin | -394,852.4% | 12.1% | 14.9% |
| EBITDA | -507,864,404 | 501.0K | 520.7K |
| Free Cash Flow | — | 197.3K | 259.9K |
| Rev Growth | — | +5.7% | +22.2% |
| Debt/Equity | 0.00 | 0.42 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |